Insights

  • Date

  • Content Type

  • Reset

Blog

How Biologicals Have Changed the Paradigm of How We Treat Diseases Today and in the Future

21.06.19

By Diane Seimetz

Biologics have been gaining importance rapidly over the past 30 years. Over this time, new developments revolutionized...

Read More

Blog

Continuous Progress in Continuous Manufacturing

3.06.19

By David Koziel

As manufacturers of biopharmaceuticals face growing challenges in the development and commercialization of products, advanced technologies, e.g....

Read More

Blog

Regulatory Science as an Important Principle of Good Consultancy Practices (“GCP”)

29.08.18

By Michael Pfleiderer

Regulatory science is the foundation of regulatory decision-making and is used to assess the quality, safety, and...

Read More

Blog

IMPD as a central document for drug development from early on

20.12.16

By Theo Tiko and Annegret Wiedemann

Our authors reflect on their experience with most recently prepared IMPDs. 

The Investigational Medicinal Product Dossier (IMPD) is a central...

Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more